iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
88 hedge funds and large institutions have $104M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.26% more ownership
Funds ownership: 27.28% → 27.54% (+0.26%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
88
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$9.95M | |
| 2 | +$2.79M | |
| 3 | +$2.28M | |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$733K |
| 5 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
+$560K |
Top Sellers
| 1 | -$4.54M | |
| 2 | -$2.59M | |
| 3 | -$843K | |
| 4 |
LPL Financial
San Diego,
California
|
-$562K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$353K |